News

The S&P 500 (SNPINDEX: ^GSPC) is offering investors a tiny yield of just 1.2% today. If you think you are being starved of dividend income, well, that's because you are. But you can do much better

Stryker (NYSE:SYK), a leading global medical technology company, reported financial results on July 31, 2025. The company delivered several key beats: Net sales (GAAP) reached $6.0 billion, topping

A bellwether stock in the lately rather up-and-down pharmaceutical sector, AbbVie (NYSE: ABBV) finished the trading week in style. The company's shares closed more than 3% higher in price thanks in

Cigna Group (NYSE:CI), a global health services company offering integrated medical, pharmacy, and specialty care solutions, released its second-quarter earnings on July 31, 2025. The company

If you're looking to invest in dividend stocks, one of the most popular ways to do it is with the Schwab U.S. Dividend Equity ETF (NYSEMKT: SCHD). The exchange-traded fund (ETF) has net assets of

DexCom (NASDAQ:DXCM) reported its second-quarter 2025 results on July 30, 2025, delivering an upbeat performance highlighted by a revenue beat and continued expansion in the key type 2 diabetes

Explore the exciting world of Illumina (NASDAQ: ILMN) with our contributing expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market

Shares of AbbVie (NYSE: ABBV) were bouncing along merrily for most of Thursday's trading session, until news of a fresh demand from the White House quashed the rally. Initially, the market was

Pfizer (NYSE: PFE) has been around for over 175 years, but it became a true household name during the COVID-19 pandemic as one of the main vaccine suppliers. That led to its stock price and revenue

Hologic (NASDAQ:HOLX), a global medical technology company specializing in diagnostics and women’s health, reported financial results for the third quarter of fiscal 2025 on July 30, 2025. The most

Five years ago, the eyes of the world were on Pfizer (NYSE: PFE). The big drugmaker was racing to develop a COVID-19 vaccine with its partner, BioNTech (NASDAQ: BNTX). Its stock was poised for a

An old country song morbidly titled "Gloom, Despair, and Agony on Me" included the lyrics, "If it weren't for bad luck, I'd have no luck at all." This might be an apt motto for UnitedHealth Group

On Tuesday, Merck (NYSE: MRK) wasn't one of the better-performing pharmaceutical stocks. In contrast to certain peers, the company's share price declined following the release of second-quarter

AstraZeneca (NASDAQ: AZN) reported an estimates-busting quarter Tuesday morning, and a satisfied market rewarded the company for it. At market close the sturdy pharmaceutical stock had risen by

UnitedHealth Group (NYSE:UNH), a leading diversified healthcare and insurance provider, reported results for the second quarter of fiscal 2025 on July 29, 2025. The most significant news was its

Merck (NYSE:MRK), a leading developer of prescription medicines, vaccines, and animal health products, released its second-quarter 2025 results on July 29, 2025. The most notable news was a beat on

For years UnitedHealth Group (NYSE: UNH) has normally been a reliable dividend stock. But an abysmal start to 2025 has wiped out many of the gains that investors have achieved in recent years, with

Healthcare stocks aren't exactly known for offering large yields, with the average healthcare stock at just 1.8% or so. You can do better than that and get reliable dividend stocks while you are at

Over the long run, dividends can make a significant difference in your returns, whether you choose to reinvest the payouts or retain the cash for other purposes. However, many companies that offer

Vertex Pharmaceuticals (NASDAQ: VRTX) has been a terrific stock to own over the past decade. The stock has outperformed the market over this period, thanks to consistent financial results and

You'd think that companies with long, successful track records and market caps in the hundreds of billions of dollars would be viewed as relatively formidable. However, that's not always the case.

Even with all the volatility and the flirting with bear-market territory, the S&P 500 index is well in the green this year, up about 8% since early January. Some stocks haven't been so lucky

In this video, I will talk about UnitedHealth Group (NYSE: UNH) and why buying the stock before it reports earnings could make sense. Watch the short video to learn more, consider subscribing, and

On July 10, 2025, Stewart Murray Lee (Head of People & Strategy) executed an open market sale of 50,000 shares of New Horizon Aircraft Ltd.(NASDAQ:HOVR), with the transaction disclosed in a Form 4